{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:40:02Z","timestamp":1790739602707,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.diabres.2022.109996","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T04:50:48Z","timestamp":1657947048000},"page":"109996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Transdermal drug delivery systems for the effective management of type 2 diabetes mellitus: A review"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2166-9876","authenticated-orcid":false,"given":"Arunachalam","family":"Thirunavukkarasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajarathinam","family":"Nithya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyadharmarajan","family":"Jeyanthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diabres.2022.109996_b0005","first-page":"323","article-title":"Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation","volume":"26","author":"Akram","year":"2013","journal-title":"Pak J Pharm Sci"},{"issue":"4","key":"10.1016\/j.diabres.2022.109996_b0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/pharmaceutics7040438","article-title":"Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the Stratum Corneum","volume":"7","author":"Alkilani","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.diabres.2022.109996_b0015","doi-asserted-by":"crossref","unstructured":"Andrews S, Lee JW, Choi SO, Prausnitz MR. Transdermal insulin delivery using microdermabrasion. Pharm Res. 2011; 28(9): 2110\u20138. doi: 10.1007\/s11095-011-0435-4. Epub 2011 Apr 16. PMID: 21499837; PMCID: PMC3152630.","DOI":"10.1007\/s11095-011-0435-4"},{"key":"10.1016\/j.diabres.2022.109996_b0020","article-title":"Nanoemulsion based hydrogel for enhanced transdermal delivery of ketoprofen","volume":"12","author":"Arora","year":"2014","journal-title":"Adv Pharm"},{"key":"10.1016\/j.diabres.2022.109996_b0025","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nchem.2857","article-title":"Glucose-responsive insulin by molecular and physical design","volume":"9","author":"Bakh","year":"2017","journal-title":"Nat Chem"},{"key":"10.1016\/j.diabres.2022.109996_b0030","doi-asserted-by":"crossref","unstructured":"Bohannon N, Bergenstal R, Cuddihy R, Kruger D, List S, Massaro E, et al. Comparison of a novel insulin bolus-patch with pen\/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter study. Diabetes Technol Ther 2011; 13(10): 1031\u20137. doi: 10.1089\/dia.2011.0047. Epub 2011 Jul 6. PMID: 21732797; PMCID: PMC4346544.","DOI":"10.1089\/dia.2011.0047"},{"key":"10.1016\/j.diabres.2022.109996_b0035","doi-asserted-by":"crossref","unstructured":"Boucaud, A. Tessier, L. Machet, L. Vaillant L, Patat F. Transdermal delivery of insulin using low frequency ultrasound. In: 2000 IEEE Ultrasonics Symposium. Proceedings. An International Symposium (Cat. No.00CH37121), 2000, pp. 1453-1456 vol.2, doi: 10.1109\/ULTSYM.2000.921597.","DOI":"10.1109\/ULTSYM.2000.921597"},{"issue":"2","key":"10.1016\/j.diabres.2022.109996_b0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0005-2736(97)00177-6","article-title":"Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin","volume":"1368","author":"Cevc","year":"1998","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.diabres.2022.109996_b0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-200342050-00004","article-title":"Transdermal drug delivery of insulin with ultradeformable carriers","volume":"42","author":"Cevc","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.diabres.2022.109996_b0050","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/mp300667p","article-title":"Effect of cationic cyclopeptides on transdermal and transmembrane delivery of insulin","volume":"10","author":"Chang","year":"2013","journal-title":"Mol Pharm"},{"issue":"28","key":"10.1016\/j.diabres.2022.109996_b0055","doi-asserted-by":"crossref","first-page":"eaba7260","DOI":"10.1126\/sciadv.aba7260","article-title":"A basal-bolus insulin regimen integrated microneedle patch for intraday postprandial glucose control","volume":"6","author":"Chen","year":"2020","journal-title":"Sci Adv"},{"issue":"9","key":"10.1016\/j.diabres.2022.109996_b0060","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/ma11091625","article-title":"Dissolving Microneedle Patches for Transdermal Insulin Delivery in Diabetic Mice: Potential for Clinical Applications","volume":"11","author":"Chen","year":"2018","journal-title":"Materials (Basel)"},{"issue":"1","key":"10.1016\/j.diabres.2022.109996_b0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2009.05.031","article-title":"Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin","volume":"139","author":"Chen","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.diabres.2022.109996_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2015.06.021","article-title":"Poly-\u03b3-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin","volume":"24","author":"Chen","year":"2015","journal-title":"Acta Biomater"},{"issue":"4","key":"10.1016\/j.diabres.2022.109996_b0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nbt1193","article-title":"Transdermal protein delivery by a coadministered peptide identified via phage display","volume":"24","author":"Chen","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.diabres.2022.109996_b0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2008.08.040","article-title":"Microneedle mediated delivery of nanoparticles into human skin","volume":"366","author":"Coulman","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.diabres.2022.109996_b0085","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.msec.2019.04.063","article-title":"3D printed microneedle patches using stereolithography (SLA) for intradermal insulin delivery","volume":"102","author":"Economidou","year":"2019","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"3","key":"10.1016\/j.diabres.2022.109996_b0090","first-page":"228","article-title":"Clinical significance of transdermal lidocaine patch","volume":"18","author":"Galer","year":"2003","journal-title":"Drug Deliv Syst"},{"key":"10.1016\/j.diabres.2022.109996_b0095","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AJP.0b013e31816778f9","article-title":"Effect of microneedle design on pain in human volunteers","volume":"24","author":"Gill","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.diabres.2022.109996_b0100","doi-asserted-by":"crossref","unstructured":"Ginsberg BH. Patch Pumps for Insulin. J Diabetes Sci Technol 2019; 13(1): 27\u201333. doi: 10.1177\/1932296818786513. Epub 2018 Aug 2. PMID: 30070604; PMCID: PMC6313281.","DOI":"10.1177\/1932296818786513"},{"key":"10.1016\/j.diabres.2022.109996_b0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2005.12.003","article-title":"Needle-free vaccine delivery","volume":"58","author":"Giudice","year":"2006","journal-title":"Adv Drug Del Rev"},{"key":"10.1016\/j.diabres.2022.109996_b0110","unstructured":"Global Transdermal Drug Delivery Market Analysis Opportunity Outlook 2024, https:\/\/www.researchnester.com\/reports\/global-transdermal-drug-delivery-market-analysis-opportunity-outlook-2024\/111."},{"key":"10.1016\/j.diabres.2022.109996_b0115","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.addr.2007.07.004","article-title":"Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models","volume":"59","author":"Godin","year":"2007","journal-title":"Adv Drug Del Rev"},{"issue":"2","key":"10.1016\/j.diabres.2022.109996_b0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/107175400266687","article-title":"Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier","volume":"7","author":"Guo","year":"2000","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.diabres.2022.109996_b0125","doi-asserted-by":"crossref","DOI":"10.1017\/S1041610205001535","article-title":"Transdermal estrogen patches for aggressive behavior in male patients with dementia: a randomized, controlled trial","volume":"17","author":"Hall","year":"2005","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"10.1016\/j.diabres.2022.109996_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/bdd.2510150210","article-title":"Pharmacokinetics of nitroglycerin and its four metabolites during nitroglycerin transdermal administration","volume":"15","author":"Han","year":"2006","journal-title":"Biopharm Drug Dispos"},{"issue":"10","key":"10.1016\/j.diabres.2022.109996_b0135","first-page":"776","article-title":"Transdermal iontophoresis of insulin: effect of penetration enhancers on blood glucose level in diabetic rats","volume":"30","author":"Hao","year":"1995","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.diabres.2022.109996_b0140","doi-asserted-by":"crossref","first-page":"119416","DOI":"10.1016\/j.ijpharm.2020.119416","article-title":"Transdermal insulin delivery with microwave and fatty acids as permeation enhancers","author":"Harjoh","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.diabres.2022.109996_b0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrendo.2011.32","article-title":"Closed-loop insulin delivery: from bench to clinical pract ice","volume":"7","author":"Hovorka","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2022.109996_b0150","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/acsnano.6b06892","article-title":"H2O2-Responsive Vesicles Integrated with Transcutaneous Patches for Glucose-Mediated Insulin Delivery","volume":"11","author":"Hu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.diabres.2022.109996_b0155","doi-asserted-by":"crossref","unstructured":"Ita KB. Transdermal drug delivery: progress and challenges. J Drug Deliv Sci Technol 2014; 24(3): 245\u2013250, ISSN 1773-2247, https:\/\/doi.org\/10.1016\/S1773-2247(14)50041-X.","DOI":"10.1016\/S1773-2247(14)50041-X"},{"key":"10.1016\/j.diabres.2022.109996_b0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/dia.2012.0096","article-title":"Transdermal Insulin Application System with Dissolving Microneedles","author":"Ito","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2022.109996_b0165","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1463-1326.2009.01150.x","article-title":"Oral insulin\u2013a review of current status, Diabetes","volume":"12","author":"Iyer","year":"2010","journal-title":"Obes Metab"},{"issue":"10","key":"10.1016\/j.diabres.2022.109996_b0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7324\/JAPS.2016.601027","article-title":"Eucerin impedes transdermal insulin delivery by sonophoresis in rats","volume":"6","author":"Jabbari","year":"2016","journal-title":"J Appl Pharmaceut Sci"},{"key":"10.1016\/j.diabres.2022.109996_b0175","doi-asserted-by":"crossref","unstructured":"Jain S, Jain V, Mahajan SC. Lipid Based Vesicular Drug Delivery Systems. Adv Pharmaceut 2014; 2014: 574673,12pages.https:\/\/doi.org\/10.1155\/2014\/574673.","DOI":"10.1155\/2014\/574673"},{"key":"10.1016\/j.diabres.2022.109996_b0180","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/ab3202","article-title":"Polymer microneedles integrated with glucose-responsive mesoporous bioactive glass nanoparticles for transdermal delivery of insulin","author":"Jiang","year":"2019","journal-title":"Biomed Phys Eng Express"},{"issue":"127","key":"10.1016\/j.diabres.2022.109996_b0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.addr.2018.03.011","article-title":"Insulin delivery systems combined with microneedle technology","volume":"1","author":"Jin","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.diabres.2022.109996_b0190","doi-asserted-by":"crossref","unstructured":"Jorge Ludmilla R, Harada Liliam K, Silva Erica C, Campos Welida F, Moreli Fernanda C, Shimamoto Gustavo, et al. Non-invasive Transdermal Delivery of Human Insulin Using Ionic Liquids: In vitro Studies. Front Pharmacol 2020; 11: 243., doi:10.3389\/fphar.2020.00243.","DOI":"10.3389\/fphar.2020.00243"},{"key":"10.1016\/j.diabres.2022.109996_b0195","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1073\/pnas.0501176102","article-title":"Design principles of chemical penetration enhancers for transdermal drug delivery","volume":"102","author":"Karande","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.diabres.2022.109996_b0200","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.addr.2007.08.019","article-title":"Current challenges in non-invasive insulin delivery systems: a comparative review","volume":"59","author":"Khafagy","year":"2007","journal-title":"Adv Drug Del Rev"},{"issue":"4","key":"10.1016\/j.diabres.2022.109996_b0205","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/152091502760306562","article-title":"Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats","volume":"4","author":"King","year":"2002","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.diabres.2022.109996_b0210","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1211\/0022357021918","article-title":"Evidence for lymphatic transport of insulin by topically applied biphasic vesicles","volume":"55","author":"King","year":"2003","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"10.1016\/j.diabres.2022.109996_b0215","first-page":"368","article-title":"The history of diabetes mellitus","volume":"13","author":"Lakhtakia","year":"2013","journal-title":"SQUMJ"},{"key":"10.1016\/j.diabres.2022.109996_b0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2013.02.040","article-title":"Skin penetration enhancers","volume":"447","author":"Lane","year":"2013","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.diabres.2022.109996_b0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0168-3659(97)00155-7","article-title":"Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment","volume":"51","author":"Langkjaer","year":"1998","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.diabres.2022.109996_b0230","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jbm.a.35869","article-title":"Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice","volume":"105","author":"Lee","year":"2017","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.diabres.2022.109996_b0235","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.biomaterials.2007.12.048","article-title":"Dissolving microneedles for transdermal drug delivery","volume":"29","author":"Lee","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.diabres.2022.109996_b0240","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1208\/s12249-015-0416-8","article-title":"Application of Microneedle Arrays for Enhancement of Transdermal Permeation of Insulin. In Vitro Experiments, Scaling Analyses and Numerical Simulations","volume":"17","author":"Leeladurga","year":"2016","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1016\/j.diabres.2022.109996_b0245","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1211\/jpp.61.08.0003","article-title":"Trypsin as a novel potential absorption enhancer for improving the transdermal delivery of macromolecules","volume":"61","author":"Li","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.diabres.2022.109996_b0250","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.actbio.2020.12.023","article-title":"Iontophoresis-driven Porous Microneedle Array Patch for Active Transdermal Drug Delivery","volume":"121","author":"Li","year":"2021","journal-title":"Acta Biomater"},{"issue":"8","key":"10.1016\/j.diabres.2022.109996_b0255","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1211\/jpp.61.08.0003","article-title":"Trypsin as a novel potential absorption enhancer for improving the transdermal delivery of macromolecules","volume":"61","author":"Li","year":"2009","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"10.1016\/j.diabres.2022.109996_b0260","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1248\/bpb.31.1574","article-title":"Transdermal delivery of insulin using trypsin as a biochemical enhancer","volume":"31","author":"Li","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.diabres.2022.109996_b0265","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1016\/j.actbio.2013.06.029","article-title":"Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats","volume":"9","author":"Ling","year":"2013","journal-title":"Acta Biomater"},{"key":"10.1016\/j.diabres.2022.109996_b0270","doi-asserted-by":"crossref","unstructured":"Lio ACS, Chia RN, Kwek MSY, Wiraja C, Madden LE, Chang H, et al. Temporal pressure enhanced topical drug delivery through micropore formation. Sci Adv 2020; 6(22): eaaz6919, DOI: 10.1126\/sciadv.aaz6919.","DOI":"10.1126\/sciadv.aaz6919"},{"key":"10.1016\/j.diabres.2022.109996_b0275","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jconrel.2012.05.030","article-title":"The Development and Characteristics of Novel Microneedle Arrays Fabricated from Hyaluronic Acid, and their Application in the Transdermal Delivery of Insulin","volume":"161","author":"Liu","year":"2012","journal-title":"J Control Release"},{"issue":"12","key":"10.1016\/j.diabres.2022.109996_b0280","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.xphs.2016.08.022","article-title":"A Nanoscale Polymeric Penetration Enhancer Based on Polylysine for Topical Delivery of Proteins and Peptides","volume":"105","author":"Luo","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.diabres.2022.109996_b0285","doi-asserted-by":"crossref","DOI":"10.1007\/s12274-020-3273-z","article-title":"Microneedle-array patch with pH-sensitive formulation for glucose-responsive insulin delivery","author":"Luo","year":"2021","journal-title":"Nano Res"},{"key":"10.1016\/j.diabres.2022.109996_b0290","doi-asserted-by":"crossref","unstructured":"Malakar J, Sen SO, Nayak AK, Sen KK. Development and evaluation of microemulsions for transdermal delivery of insulin. ISRN Pharm 2011; 2011: 780150. doi: 10.5402\/2011\/780150. Epub 2011 Jul 7. PMID: 22389858; PMCID: PMC3263709.","DOI":"10.5402\/2011\/780150"},{"issue":"4","key":"10.1016\/j.diabres.2022.109996_b0295","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jsps.2012.02.001","article-title":"Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery","volume":"20","author":"Malakar","year":"2012","journal-title":"Saudi Pharm J"},{"issue":"12","key":"10.1016\/j.diabres.2022.109996_b0300","doi-asserted-by":"crossref","first-page":"1701e8","DOI":"10.1023\/A:1013318412527","article-title":"Contributions of electromigration and electroosmosis to iontophoretic drug delivery","volume":"18","author":"Marro","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.diabres.2022.109996_b0305","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11095-005-8498-8","article-title":"Microinfusion using hollow microneedles","volume":"23","author":"Martanto","year":"2006","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.diabres.2022.109996_b0310","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3109\/10717544.2016.1155243","article-title":"Development of transferosomal gel for trans-dermal delivery of insulin using iodine complex","volume":"23","author":"Marwah","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.diabres.2022.109996_b0315","unstructured":"Mbaye G, Ndiaye A, Diouf LA, Diallo AS, Diedhiou A, Sene M, et al. Developpement d'une matrice ethylcellulose\/eudragit pour la liberation controlee et continue de l'insuline [Development of Ethylcellulose\/Eudragit matrix for controlled and continuous release of insulin]. Mali Med 2009; 24(3): 11\u20136. French. PMID: 20093223."},{"key":"10.1016\/j.diabres.2022.109996_b0320","doi-asserted-by":"crossref","first-page":"13755","DOI":"10.1073\/pnas.2331316100","article-title":"Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies","volume":"100","author":"McAllister","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.diabres.2022.109996_b0325","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/ebch.623","article-title":"Cochrane review: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus","volume":"5","author":"Misso","year":"2010","journal-title":"Evid Based Child Health"},{"key":"10.1016\/j.diabres.2022.109996_b0330","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat Rev Drug discov"},{"key":"10.1016\/j.diabres.2022.109996_b0335","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1039\/c3cs60436e","article-title":"Emerging micro-and nanotechnology based synthetic approaches for insulin delivery","volume":"43","author":"Mo","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.diabres.2022.109996_b0340","doi-asserted-by":"crossref","unstructured":"Mohammad EA, Elshemey WM, Elsayed AA, Abd-Elghany AA. Electroporation Parameters for Successful Transdermal Delivery of Insulin. Am J Ther. 2016; 23(6): e1560\u2013e1567. doi: 10.1097\/MJT.0000000000000198. PMID: 25782568.","DOI":"10.1097\/MJT.0000000000000198"},{"key":"10.1016\/j.diabres.2022.109996_b0345","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(97)06234-X","article-title":"Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus","volume":"350","author":"Morris","year":"1997","journal-title":"The Lancet"},{"issue":"9","key":"10.1016\/j.diabres.2022.109996_b0350","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/jps.20682","article-title":"Lipid and electroosmosis enhanced transdermal delivery of insulin by electroporation","volume":"95","author":"Murthy","year":"2006","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.diabres.2022.109996_b0355","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/0971-6866.69350","article-title":"Association of polymorphisms in leptin receptor gene with obesity and type 2 diabetes in the local population of Coimbatore","volume":"16","author":"Murugesan","year":"2010","journal-title":"Indian J Hum Genet"},{"issue":"12","key":"10.1016\/j.diabres.2022.109996_b0360","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1039\/c2nr30651d","article-title":"Gold nanorods in an oil-base formulation for transdermal treatment of type 1 diabetes in mice","volume":"4","author":"Nose","year":"2012","journal-title":"Nanoscale"},{"issue":"8","key":"10.1016\/j.diabres.2022.109996_b0365","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1248\/bpb.19.1049","article-title":"Dissociation of insulin oligomers and enhancement of percutaneous absorption of insulin","volume":"19","author":"Ogiso","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.diabres.2022.109996_b0370","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2022.109996_b0375","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrd836","article-title":"New horizons-alternative routes for insulin therapy","volume":"1","author":"Owens","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.diabres.2022.109996_b0380","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1464-5491.2003.01076.x","article-title":"Alternative routes of insulin delivery","volume":"20","author":"Owens","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2022.109996_b0385","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1039\/C9NH00576E","article-title":"Electrothermal patches driving the transdermal delivery of insulin","volume":"5","author":"Pagneux","year":"2020","journal-title":"Nanoscale Horiz"},{"issue":"8","key":"10.1016\/j.diabres.2022.109996_b0390","first-page":"649","article-title":"The enhancing effect of electroporation and iontophoresis on the permeation of insulin through human skin","volume":"37","author":"Pan","year":"2002","journal-title":"Yao Xue Xue Bao"},{"issue":"3","key":"10.1016\/j.diabres.2022.109996_b0395","first-page":"335","article-title":"Dose comparison of ultrasonic transdermal insulin delivery to subcutaneous insulin injection","volume":"3","author":"Park","year":"2008","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"10.1016\/j.diabres.2022.109996_b0400","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/dia.2010.0183","article-title":"Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes","volume":"13","author":"Pettis","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2022.109996_b0405","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2337\/diacare.25.3.593","article-title":"Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes","volume":"25","author":"Pickup","year":"2002","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2022.109996_b0410","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0378-5173(03)00034-6","article-title":"Transdermal iontophoresis of insulin. II Physicochemical considerations","volume":"254","author":"Pillai","year":"2003","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.diabres.2022.109996_b0415","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1211\/0022357022197","article-title":"Transdermal iontophoresis of insulin. Part 1: A study on the issues associated with the use of platinum electrodes on rat skin","volume":"55","author":"Pillai","year":"2003","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.diabres.2022.109996_b0420","doi-asserted-by":"crossref","unstructured":"Pillai O, Kumar N, Dey CS, Borkute, Sivaprasad N, Panchagnula R. Transdermal iontophoresis of insulin: III. Influence of electronic parameters. Methods Find Exp Clin Pharmacol 2004; 26(6): 399\u2013408. PMID: 15349135.","DOI":"10.1358\/mf.2004.26.6.831314"},{"issue":"2","key":"10.1016\/j.diabres.2022.109996_b0425","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0168-3659(03)00065-8","article-title":"Transdermal iontophoresis of insulin. V. Effect of terpenes","volume":"88","author":"Pillai","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.diabres.2022.109996_b0430","doi-asserted-by":"crossref","unstructured":"Ping W, Yuan-yuan Y, Jia-li B, Xiao-an W. Enhanced transdermal insulin delivery by electroporation. In: 2008 International Conference on Technology and Applications in Biomedicine; 2008. doi:10.1109\/itab.2008.4570604.","DOI":"10.1109\/ITAB.2008.4570604"},{"key":"10.1016\/j.diabres.2022.109996_b0435","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.diabres.2022.109996_b0440","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd1304","article-title":"Current status and future potential of transdermal drug delivery","volume":"3","author":"Prausnitz","year":"2004","journal-title":"Nat Rev Drug discov"},{"key":"10.1016\/j.diabres.2022.109996_b0445","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.addr.2003.10.023","article-title":"Microneedles for transdermal drug delivery","volume":"56","author":"Prausnitz","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.diabres.2022.109996_b0450","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1248\/cpb.35.4915","article-title":"Evaluation of in vitro and in situ transdermal absorption of drugs in pig and rat skin","volume":"35","author":"Priborsky","year":"1987","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"1\u20132","key":"10.1016\/j.diabres.2022.109996_b0455","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijpharm.2012.07.035","article-title":"Novel lyophilized hydrogel patches for convenient and effective administration of microneedle-mediated insulin delivery","volume":"437","author":"Qiu","year":"2012","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.diabres.2022.109996_b0460","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/03639041003682012","article-title":"Investigation on the synergistic effect of a combination of chemical enhancers and modulated iontophoresis for transdermal delivery of insulin","volume":"36","author":"Rastogi","year":"2010","journal-title":"Drug Dev Ind Pharm"},{"issue":"11","key":"10.1016\/j.diabres.2022.109996_b0465","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3109\/03639041003786193","article-title":"Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin","volume":"36","author":"Rastogi","year":"2010","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.diabres.2022.109996_b0470","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1081\/PDT-49679","article-title":"Effect of chemical penetration enhancer and iontophoresis on the in vitro percutaneous absorption enhancement of insulin through porcine epidermis","volume":"10","author":"Rastogi","year":"2005","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.diabres.2022.109996_b0475","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.08.009","article-title":"Chemically controlled closed-loop insulin delivery","volume":"132","author":"Ravaine","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.diabres.2022.109996_b0480","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13346-015-0251-1","article-title":"Inkjet printing of insulin microneedles for transdermal delivery","volume":"5","author":"Ross","year":"2015","journal-title":"Drug Deliv and Transl Res"},{"issue":"5","key":"10.1016\/j.diabres.2022.109996_b0485","first-page":"84","article-title":"Transdermal Patches of Chitosan Nanoparticles for Insulin Delivery","volume":"7","author":"Sadhasivam","year":"2015","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.diabres.2022.109996_b0490","unstructured":"Sampath Kumar KP, Bhowmik D, Komala M. Transdermal Sonophoresis Technique- An Approach for Controlled Drug Delivery. Indian J Res Pharm Biotechnol 2013; 1(3): 379\u2013381."},{"key":"10.1016\/j.diabres.2022.109996_b0495","unstructured":"Sattley M. The history of diabetes: diabetes health; 2015. Available from: https:\/\/www.diabeteshealth.com\/the-history-of-diabetes\/."},{"key":"10.1016\/j.diabres.2022.109996_b0500","unstructured":"Segal, M., Patches, pumps and timed release: new ways to deliver drugs. Food Drug Admin http:\/\/www.fda.gov\/bbs\/topics\/consumer\/CON00112.html, Editor. 2007."},{"issue":"1","key":"10.1016\/j.diabres.2022.109996_b0505","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0005-2736(02)00453-4","article-title":"Transdermal insulin delivery using lipid enhanced electroporation","volume":"1564","author":"Sen","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"265","key":"10.1016\/j.diabres.2022.109996_b0510","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2017.03.041","article-title":"A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin","volume":"10","author":"Seong","year":"2017","journal-title":"J Control Release"},{"issue":"15","key":"10.1016\/j.diabres.2022.109996_b0515","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.3390\/app10155341","article-title":"Vesicular Emulgel Based System for Transdermal Delivery of Insulin: Factorial Design and in Vivo Evaluation","volume":"10","author":"Shehata","year":"2020","journal-title":"Appl Sci"},{"issue":"12","key":"10.1016\/j.diabres.2022.109996_b0520","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/1753-0407.12538","article-title":"Cardioprotective effects of pectin-insulin patch in streptozotocin-induced diabetic rats","volume":"9","author":"Sibiya","year":"2017","journal-title":"J Diabetes"},{"issue":"2","key":"10.1016\/j.diabres.2022.109996_b0525","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2006.12.006","article-title":"Topical iodine facilitates transdermal delivery of insulin","volume":"118","author":"Sintov","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.diabres.2022.109996_b0530","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-0846.2005.00107.x","article-title":"Clinical microneedle injection of methyl nicotinate: Stratum corneum penetration","volume":"11","author":"Sivamani","year":"2005","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.diabres.2022.109996_b0535","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nm.2182","article-title":"Dissolving polymer microneedle patches for influenza vaccination","volume":"16","author":"Sullivan","year":"2010","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.diabres.2022.109996_b0540","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2008.07.015","article-title":"A solid-in-oil nanodispersion for transcutaneous protein delivery","volume":"131","author":"Tahara","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.diabres.2022.109996_b0545","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1039\/c2md20059g","article-title":"Goto M Transdermal delivery of insulin using a solid-in-oil nanodispersion enhanced by arginine-rich peptides","volume":"3","author":"Tahara","year":"2012","journal-title":"Med Chem Commun"},{"issue":"48","key":"10.1016\/j.diabres.2022.109996_b0550","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.1039\/c0cc03600e","article-title":"Transcutaneous immunization by a solid-in-oil nanodispersion","volume":"46","author":"Tahara","year":"2010","journal-title":"Chem Commun (Camb)"},{"issue":"1\u20132","key":"10.1016\/j.diabres.2022.109996_b0555","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2006.07.002","article-title":"Effect of electroporation and pH on the iontophoretic transdermal delivery of human insulin","volume":"326","author":"Tokumoto","year":"2006","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.diabres.2022.109996_b0560","doi-asserted-by":"crossref","first-page":"106e21","DOI":"10.1159\/000091978","article-title":"Overcoming the stratum corneum: the modulation of skin penetration","volume":"19","author":"Trommer","year":"2006","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.diabres.2022.109996_b0565","first-page":"P173","article-title":"Transdermal delivery of insulin using amidated pectin hydrogel patches","volume":"21","author":"Tufts","year":"2010","journal-title":"Endocrine Abstr"},{"key":"10.1016\/j.diabres.2022.109996_b0570","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrd4477","article-title":"Managing diabetes with nanomedicine: challenges and opportunities","volume":"14","author":"Veiseh","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.diabres.2022.109996_b0575","author":"Wang","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.diabres.2022.109996_b0580","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2003.10.025","article-title":"Penetration enhancers","volume":"56","author":"Williams","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"10.1016\/j.diabres.2022.109996_b0585","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1089\/dia.2011.0077","article-title":"Painless skin electroporation as a novel way for insulin delivery","volume":"13","author":"Wong","year":"2011","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.diabres.2022.109996_b0590","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10544-010-9419-0","article-title":"Sustained release of insulin through skin by intradermal microdelivery system","volume":"12","author":"Wu","year":"2010","journal-title":"Biomed Microdevices"},{"key":"10.1016\/j.diabres.2022.109996_b0595","doi-asserted-by":"crossref","unstructured":"Yang R, Wei T, Goldberg H, Wang W, Cullion K, Kohane DS. Getting Drugs Across Biological Barriers. Adv Mater 2017.","DOI":"10.1002\/adma.201606596"},{"key":"10.1016\/j.diabres.2022.109996_b0600","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41378-020-00224-z","article-title":"Smartphone-powered iontophoresis-microneedle array patch for controlled transdermal delivery","volume":"6","author":"Yang","year":"2020","journal-title":"Microsyst Nanoeng"},{"key":"10.1016\/j.diabres.2022.109996_b0605","doi-asserted-by":"crossref","unstructured":"Yerramsetty KM, Rachakonda VK, Neely BJ, Madihally SV, Gasem KA. Effect of different enhancers on the transdermal permeation of insulin analog. Int J Pharm 2010; 398(1-2): 83\u201392. doi: 10.1016\/j.ijpharm.2010.07.029. Epub 2010 Aug 3. PMID: 20667506; PMCID: PMC2934860.","DOI":"10.1016\/j.ijpharm.2010.07.029"},{"key":"10.1016\/j.diabres.2022.109996_b0610","doi-asserted-by":"crossref","unstructured":"Yu J, Wang J, Zhang Y, Chen G, Mao W, Ye Y, Kahkoska AR, Buse JB, Langer R, Gu Z. Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs. Nat Biomed Eng 2020; 4(5): 499\u2013506. doi: 10.1038\/s41551-019-0508-y. Epub 2020 Feb 3. PMID: 32015407; PMCID: PMC7231631.","DOI":"10.1038\/s41551-019-0508-y"},{"key":"10.1016\/j.diabres.2022.109996_b0615","doi-asserted-by":"crossref","unstructured":"Yu J, Zhang,Y, Yea,Y, DiSantoa,R, Suna,W, Ransona, D, et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. PNAS 2015; 112 (27): 8260-8265.","DOI":"10.1073\/pnas.1505405112"},{"key":"10.1016\/j.diabres.2022.109996_b0620","doi-asserted-by":"crossref","unstructured":"Zejun W, Wang J, Li H, Yu J, Chen G, Kahkoska AR, et al. Dual self-regulated delivery of insulin and glucagon by a hybrid patch. Proc Natl Acad Sci 2020; 117(47): 29512\u201329517;DOI:10.1073\/pnas.2011099117.","DOI":"10.1073\/pnas.2011099117"},{"key":"10.1016\/j.diabres.2022.109996_b0625","doi-asserted-by":"crossref","unstructured":"Zhao J, Wu Y, Chen J, Lu B, Xiong H, Tang Z, et al. In vivo monitoring of microneedle-based transdermal drug delivery of insulin. J Innov Opt Health Sci 2018; 11(5): 1850032.","DOI":"10.1142\/S1793545818500323"},{"key":"10.1016\/j.diabres.2022.109996_b0630","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2010.03.041","article-title":"Transdermal delivery of insulin using microneedle rollers in vivo","volume":"392","author":"Zhou","year":"2010","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.diabres.2022.109996_b0635","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1021\/acsbiomaterials.0c00273","article-title":"Combined Silk Fibroin Microneedles for Insulin Delivery","volume":"6","author":"Zhu","year":"2020","journal-title":"ACS Biomater Sci Eng"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:24:46Z","timestamp":1759173886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":127,"alternative-id":["S0168822722008105"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109996","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal drug delivery systems for the effective management of type 2 diabetes mellitus: A review","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109996"}}